Biographical Sketch
Marie Siemionow, MD, PhD, was awarded her medical degree by the Poznan Medical Academy in 1974, after which she completed her residency in orthopedics, and then earned a PhD in microsurgery. In 1985, she completed a hand surgery fellowship at the Christine Kleinert Institute for Hand and Microsurgery in Louisville, Ky. Since 1995 she has been Director of Plastic Surgery Research, and Head of Microsurgery Training in the Plastic Surgery Department of Cleveland Clinic.
In 2005, she was awarded a faculty appointment as Professor of Surgery in the Department of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Most recently, she received an honorary academic appointment as Professor of Surgery at the Medical University in Poznan, Poland.
Dr. Siemionow is the first U.S. physician to receive Institutional Review Board approval for facial transplantation surgery.
Specialty Interests
hand surgery, microsurgery, peripheral nerve surgery, face and hand transplantation
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/1/2008, Dr.
Siemionow has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Siemionow receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
SanuWave, Inc.
Tolera Therapeutics, Inc.
Inventor Share. Dr. Siemionow may receive future financial benefits from the Cleveland Clinic for inventions or discoveries related to the companies shown below:
Tolera Therapeutics, Inc.
